Arcus Biosciences (RCUS) Shares Plunge Nearly 20% Amid Clinical Data Release and Stock Offering
· gurufocus.com
On October 21, 2026, Arcus Biosciences Inc (NYSE: RCUS) experienced a sharp decline in its stock price, dropping nearly 20% to close at $19.10 following the rel
On October 21, 2026, Arcus Biosciences Inc (NYSE: RCUS) experienced a sharp decline in its stock price, dropping nearly 20% to close at $19.10 following the rel...